Canakinumab For The Treatment of Amyloidosis Secondary to Lung Cancer

Journal Title: Journal of European Internal Medicine Professionals (JEIMP) - Year 2023, Vol 1, Issue 3

Abstract

hakanozer724@gmail.com, yozturk29@gmail.com, dr.fyonet@gmail.com, i_baloglu@hotmail.com, ucmdkt@gmail.com

Authors and Affiliations

Hakan Özer, Yasin Öztürk, Fethi Yönet, İsmail Baloğlu, Kultiğin Türkmen

Keywords

Related Articles

A Comparative Analysis of English and Turkish Hashtags on Allergic Rhinitis

Background: In an era where social media serves as a powerful medium for information dissemination and interaction, this study focuses on examining and comparing social media hashtags in the English and Turkish languages...

Are Allergic Diseases a Risk Factor for Systemic Side Effects After COVID-19 Vaccines?

Background: In clinical trials of currently-approved COVID-19 vaccines, patients with a known allergy or a history of anaphylaxis were excluded from the studies. This situation creates doubts about the risk and type of s...

Neuromuscular Dysfunction and Electrophysiological Findings in Patients With Hypothyroidism and Hyperthyroidism

Background: We aimed to determine the frequency of neuropathy and myopathy in newly diagnosed hypothyroid and hyperthyroid patients and to investigate the correlation between serum creatine kinase (CK) concentration and...

Musculoskeletal and Neurological Examination Findings in Post-COVID-19

Background: This study investigated the musculoskeletal and neurological examination findings in symptomatic patients who had previously experienced COVID-19. Material and Methods: A prospective cohort of 101 patients...

Retrospective Analysis of Prognostic Factors in Patients with Small Cell Lung Cancer

Background: The goal of this study is to examine how small cell lung cancer (SCLC) prognosis and survival are impacted by pre-treatment clinical characteristics and laboratory data. Material and Method: The 118 patients...

Download PDF file
  • EP ID EP719143
  • DOI https://doi.org/10.5281/zenodo.8134945
  • Views 39
  • Downloads 0

How To Cite

Hakan Özer, Yasin Öztürk, Fethi Yönet, İsmail Baloğlu, Kultiğin Türkmen (2023). Canakinumab For The Treatment of Amyloidosis Secondary to Lung Cancer. Journal of European Internal Medicine Professionals (JEIMP), 1(3), -. https://europub.co.uk./articles/-A-719143